Antibacterial medicine sales in Germany are forecasted to show a steady but minimal increase from 2024 to 2028. Sales are predicted to grow from 981.3 million US Dollars PPP in 2024 to 982.9 million US Dollars PPP by 2028. Based on the provided data, this corresponds to an average annual growth rate (CAGR) of approximately 0.08% over these five years. In 2023, the actual value stood at 981.0 million US Dollars PPP, indicating a slight upward trend from the last actual data point to 2024.
Year-by-year growth rates are observed to be minimal, ranging from slight increases of around 0.05% to 0.06% year-on-year, showing stability in the market with no significant fluctuations or declines expected.
Future trends to watch for include:
- Potential impact of new regulations on the pharmaceutical market in the EU and Germany.
- Introduction of new more effective antibacterial drugs or generic options which may shift market dynamics.
- Changes in healthcare policies that might affect prescription rates of antibacterial medicines.
- Possible resistance to antibacterial medications which could drive the development and sales of new treatments.
